BAMFebruary 24, 2026 at 6:00 PM UTCFinancial Services

BAM Acquires Ori to Bolster AI Infrastructure, Yet Valuation and Execution Risks Loom

Read source article

What happened

Brookfield Asset Management announced the acquisition of AI cloud company Ori Industries, merging it into its Radian unit to expand its AI infrastructure capabilities. This move aligns with BAM's strategic push into AI, highlighted in its recent master report as a key growth driver alongside a dedicated $10B fund. Despite the strategic fit, BAM's shares remained flat at $47.88, reflecting market skepticism or already priced-in expectations given the stock's high multiples. The DeepValue report cautions that BAM trades at 33x P/E, embedding sustained growth, and warns of risks like AI project delays and fundraising slowdowns. While the acquisition strengthens BAM's AI platform, it does not immediately address the valuation concerns or execution challenges outlined in the bear scenario.

Implication

BAM's acquisition of Ori Industries enhances its technical capabilities in AI cloud infrastructure, potentially accelerating deployment and attracting LP interest for its AI fund. However, this comes amidst a crowded AI investment landscape and regulatory hurdles in Europe, which could delay returns and strain resources. The flat stock price post-announcement suggests the market is not overly optimistic, aligning with the report's view that growth is already discounted. For investors, this reinforces the need to monitor fundraising metrics and AI project milestones closely, as any slippage could trigger multiple compression. Overall, while the move is strategically sound, it does not justify a re-rating without tangible progress in fee-bearing capital growth and project execution.

Thesis delta

This acquisition does not materially shift the core investment thesis, which remains focused on waiting for a valuation pullback or clearer evidence of durable high-teens FRE growth. The Ori acquisition supports the AI narrative but does not mitigate the high multiples, execution risks, or fundraising pressures highlighted in the report. Therefore, the thesis stays unchanged: patience is warranted until either price declines to the mid-$40s or operational milestones confirm robust growth.

Confidence

moderate